ALDER BIOPHARMACEUTICALS INC
Q4 2018 13F Holders
CUSIP
014339AA3
Type
Debt
Class
NOTE 2.500% 2/0
Num filings
30
Total reported value, excl. options
$224 M
Compare 2018 Q4 to
2020 Q1
2019 Q4
2019 Q3
2019 Q2
2019 Q1
2018 Q3
2018 Q2
2018 Q1
Manager
Report Date
Value ($000)
Principal
Option Type